Dual actions of cilnidipine in human internal thoracic artery: Inhibition of calcium channels and enhancement of endothelial nitric oxide synthase

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 4, 2011, Pages 1063-1069

  Fan, Li ^a,b   Yang, Qin ^c   Xiao, Xiao Qiu ^d   Grove, Kevin L ^d   Huang, Yu ^c   Chen, Zhi Wu ^b   Furnary, Anthony ^a   He, Guo Wei ^a,c,e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CILNIDIPINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NIFEDIPINE;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DENSITOMETRY; DRUG ACTIVITY; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; VASODILATATION;

AGED; BLOTTING, WESTERN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CYCLIC GMP; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MAMMARY ARTERIES; MIDDLE AGED; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 79952989967     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.01.048     Document Type: Article

References (27)

1. G.W. He Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice Ann Thorac Surg 67 1999 277 284
2. M.R. Sarabu, J.A. McClung, A. Fass, and G.E. Reed Early postoperative spasm in left internal mammary artery bypass grafts Ann Thorac Surg 44 1987 199 200 (Pubitemid 17119325)
3. G.W. He Contractility of the human internal mammary artery at the distal section increases toward the end. Emphasis on not using the end of the internal mammary artery for grafting J Thorac Cardiovasc Surg 106 1993 406 411
4. G.W. Stone, and G.O. Hartzler Spontaneous reversible spasm in an internal mammary artery graft causing acute myocardial infarction Am J Cardiol 64 1989 822 823 (Pubitemid 19237979)
5. H. Kitamura, K. Nakayama, and T. Kitano A case of refractory spasm of multiple coronary arteries and left internal thoracic artery graft following off-pump CABG Kyobu Geka 54 2001 1103 1106
6. G.W. He, T.E. Acuff, W.H. Ryan, C.Q. Yang, and M.J. Mack Functional comparison between the human inferior epigastric artery and internal mammary artery. Similarities and differences J Thorac Cardiovasc Surg 109 1995 13 20
7. R.E. Harskamp, J.D. McNeil, M.W. van Ginkel, R.B. Bastos, C.E. Baisden, and J.H. Calhoon Postoperative internal thoracic artery spasm after coronary artery bypass grafting Ann Thorac Surg 85 2008 647 649
8. Y. Tabel, H. Hepaguslar, C. Erdal, H. Catalyurek, U. Acikel, and Z. Elar Diltiazem provides higher internal mammary artery flow than nitroglycerin during coronary artery bypass grafting surgery Eur J Cardiothorac Surg 25 2004 553 559 (Pubitemid 38376069)
9. G.W. He, F.L. Rosenfeldt, B.F. Buxton, and J.A. Angus Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery spasm Circulation 80 3 Pt 1 1989 I141 I150
10. A. Nap, M.J. Mathy, J.C. Balt, M. Pfaffendorf, and P.A. van Zwieten The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists Fundam Clin Pharmacol 18 2004 309 319 (Pubitemid 38758698)
11. W.B. Stason, C.H. Schmid, D. Niedzwiecki, G.W. Whiting, J.F. Caubet, and D. Cory Safety of nifedipine in angina pectoris: a meta-analysis Hypertension 33 1999 24 31 (Pubitemid 29061837)
12. J. Minami, Y. Kawano, Y. Makino, H. Matsuoka, and S. Takishita Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension Br J Clin Pharmacol 50 2000 615 620 (Pubitemid 32010021)
13. S. Fujii, K. Kameyama, M. Hosono, Y. Hayashi, and K. Kitamura Effect of cilnidipine, a novel dihydropyridine Ca++-channel antagonist, on N-type Ca++ channel in rat dorsal root ganglion neurons J Pharmacol Exp Ther 280 1997 1184 1191 (Pubitemid 27166712)
14. H.S. Leung, X. Yao, F.P. Leung, W.H. Ko, Z.Y. Chen, and M. Gollasch Cilnidipine, a slow-acting Ca2+ channel blocker, induces relaxation in porcine coronary artery: role of endothelial nitric oxide and [Ca2+]i Br J Pharmacol 147 2006 55 63 (Pubitemid 43069096)
15. N. Kobayashi, Y. Mori, S. Mita, S. Nakano, T. Kobayashi, and Y. Tsubokou Effects of cilnidipine on nitric oxide and endothelin-1 expression and extracellular signal-regulated kinase in hypertensive rats Eur J Pharmacol 422 2001 149 157 (Pubitemid 32595586)
16. X.Q. Xiao, K.L. Grove, B.E. Grayson, and M.S. Smith Inhibition of uncoupling protein expression during lactation: role of leptin Endocrinology 145 2004 830 838 (Pubitemid 38183827)
17. T. Shiga, Y. Yamada, N. Matsuda, T. Tanaka, A. Urae, and M. Hashiquchi Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects Heart Vessel 22 2007 404 409 (Pubitemid 350201437)
18. Z.W. Chen, Y. Huang, Q. Yang, X.W. Li, W. Wei, and G.W. He Urocortin-induced relaxation in the human internal mammary artery Cardiovasc Res 65 2005 913 920 (Pubitemid 40249735)
19. D.J. Triggle L-type calcium channels Curr Pharm Des 12 2006 443 457
20. D.J. Triggle Calcium, calcium channels, and calcium channel antagonists Can J Physiol Pharmacol 68 1990 1474 1481
21. S. Adachi-Akahane Pharmacological basis of Ca2+ channels and Ca2+ channel antagonists Clin Calcium 15 2005 1589 1597
22. A. Matsuno, F. Ide, H. Tanaka, S. Asano, S. Miyawaki, and T. Uno Oral administration of cilnidipine to patients with hypertensive intracerebral hemorrhage in the acute stage: significance and role of an N-type calcium channel blocker Ir J Med Sci 2008 Oct 8 [Epub ahead of print]
23. Japanese Society of Hypertension Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004) Hypertens Res 29 Suppl 2006 S1 S105
24. A. Nap, M.J. Mathy, J.C. Balt, M. Pfaffendorf, and P.A. van Zwieten The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists Fundam Clin Pharmacol 18 2004 309 319 (Pubitemid 38758698)
25. D.H. Endemann, and E.L. Schiffrin Endothelial dysfunction J Am Soc Nephrol 15 2004 1983 1992 (Pubitemid 39031337)
26. J.A. Suwaidi, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Holmes Jr., and A. Lerman Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction Circulation 101 2000 948 954 (Pubitemid 30131694)
27. K. Sakamoto, T. Kawakami, M. Shimada, A. Yamaguchi, M. Kuwagata, and M. Saito Histological protection by cilnidipine, a dual L/N-type Ca(2+) channel blocker, against neurotoxicity induced by ischemia-reperfusion in rat retina Exp Eye Res 88 2009 974 982 Epub 2009 Jan 3